Sorrento Therapeutics Inc (SRNE)
0.024
0.00 (0.00%)
USD |
OTCM |
Apr 18, 16:00
Sorrento Therapeutics Free Cash Flow (Quarterly): -55.80M for June 30, 2023
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2023 | -55.80M |
| March 31, 2023 | -49.54M |
| December 31, 2022 | -72.86M |
| September 30, 2022 | -65.01M |
| June 30, 2022 | -83.69M |
| March 31, 2022 | -85.95M |
| December 31, 2021 | -74.35M |
| September 30, 2021 | -84.29M |
| June 30, 2021 | -82.01M |
| March 31, 2021 | -50.05M |
| December 31, 2020 | -21.23M |
| September 30, 2020 | -67.79M |
| June 30, 2020 | -38.47M |
| March 31, 2020 | -38.57M |
| December 31, 2019 | -37.88M |
| September 30, 2019 | -47.92M |
| June 30, 2019 | -49.09M |
| March 31, 2019 | -49.54M |
| December 31, 2018 | -50.42M |
| September 30, 2018 | -23.64M |
| June 30, 2018 | -24.49M |
| March 31, 2018 | -24.41M |
| December 31, 2017 | -46.45M |
| September 30, 2017 | -15.25M |
| June 30, 2017 | -22.37M |
| Date | Value |
|---|---|
| March 31, 2017 | -26.08M |
| December 31, 2016 | -19.69M |
| September 30, 2016 | -23.51M |
| June 30, 2016 | -13.81M |
| March 31, 2016 | -20.78M |
| December 31, 2015 | -17.92M |
| September 30, 2015 | -19.80M |
| June 30, 2015 | 1.138M |
| March 31, 2015 | -9.19M |
| December 31, 2014 | -7.814M |
| September 30, 2014 | -5.831M |
| June 30, 2014 | -6.492M |
| March 31, 2014 | -9.218M |
| December 31, 2013 | -7.272M |
| September 30, 2013 | -3.623M |
| June 30, 2013 | -3.836M |
| March 31, 2013 | -2.689M |
| December 31, 2012 | -1.386M |
| September 30, 2012 | -1.180M |
| June 30, 2012 | -0.7564M |
| March 31, 2012 | -1.023M |
| December 31, 2011 | -0.7801M |
| September 30, 2011 | -0.6519M |
| June 30, 2011 | -1.800M |
| March 31, 2011 | -0.5635M |
Free Cash Flow Definition
Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.
Free Cash Flow (Quarterly) Range, Past 5 Years
-85.95M
Minimum
Mar 2022
-21.23M
Maximum
Dec 2020
-59.09M
Average
-55.80M
Median
Jun 2023
Free Cash Flow (Quarterly) Benchmarks
| Scilex Holding Co | -5.557M |
| AIM ImmunoTech Inc | -9.956M |
| Perspective Therapeutics Inc | -9.097M |
| Protalix BioTherapeutics Inc | 3.345M |
| Armata Pharmaceuticals Inc | -10.51M |